Royalty Pharma Net Profit Falls 49% Year Over Year in Q3 2026
Net profit attributable to Royalty Pharma fell 49% year over year in the third quarter of 2026.
Related stories
MGE Energy reports third-quarter EPS of $1.48
L impact | EARNINGS | Nov 04, 2026, 02:00 PM UTC
MGE Energy Reports Third-Quarter Net Income of $56.4M
L impact | EARNINGS | Nov 04, 2026, 02:00 PM UTC
G R Infraprojects Reports September-Quarter Revenue of 23.25 Billion Rupees
L impact | EARNINGS | Nov 04, 2026, 01:59 PM UTC
G R Infraprojects Reports September-Quarter Consolidated Net Profit of 2.93 Billion Rupees
M impact | EARNINGS | Nov 04, 2026, 01:58 PM UTC
Pandora Raises 2026 EBIT Margin Guidance to 22.5%-23%
Pandora raised its 2026 EBIT margin guidance to 22.5%-23%.
M impact | EARNINGS | Nov 04, 2026, 01:57 PM UTC
Pandora Raises 2026 Organic Growth Outlook to 2–3%
M impact | EARNINGS | Nov 04, 2026, 01:57 PM UTC